2015
$2.1M
from 5 investors over 5 rounds
HepaTx Corporation raised undisclosed on May 20, 2021
Investors: Bioverge
HepaTx Corporation raised undisclosed on December 20, 2020
Investors: Sand Hill Angels
HepaTx Corporation raised undisclosed on November 4, 2020
Investors: Asymmetry Ventures
HepaTx Corporation raised $2.1M on August 20, 2018
Investors: Grey Sky Venture Partners and Y Combinator